The Latest Analyst Ratings For Catalyst Pharmaceuticals
The Latest Analyst Ratings For Catalyst Pharmaceuticals
catalyst pharmaceuticals的最新分析師評級
The standing of...5 analysts have expressed a variety of opinions on Catalyst Pharmaceuticals (NASDAQ:CPRX) over the past quarter, offering a diverse set of opinions from bullish to bearish.
在過去的一個季度中，有5名分析師對催化製藥（NASDAQ:CPRX）發表了各種觀點，涵蓋了從看好到看淡的多種觀點。
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
總結他們最近的評估，下表展示了過去30天內不斷變化的情緒，並將其與之前的幾個月進行了比較。
Analysts have recently evaluated Catalyst Pharmaceuticals and provided 12-month price targets. The average target is $29.2, accompanied by a high estimate of $31.00 and a low estimate of $26.00. Witnessing a positive shift, the current average has risen by 9.77% from the previous average price target of $26.60.
分析師最近對催化製藥進行了評估，並提供了12個月的價格目標。平均目標爲29.2美元，最高估值爲31.00美元，最低估值爲26.00美元。目前的平均值比之前的平均目標價格26.60美元上漲了9.77％。
Decoding Analyst Ratings: A Detailed Look
分析師評級解讀：詳細解析
The standing of...
通過對...
登入免費觀看全文
登入/註冊